Healthtech startup Healthplix has raised $6 Mn in its Series B funding round. Chiratae led the fresh tranche of the Series B round with Rs 5.73 crore, shows regulatory filings. Kalaari and JSW have invested Rs 2.8 crore and Rs 2.1 crore respectively. Healthplix allotted 22,295 Series B CCPS at an issue price of Rs 3,872 per share to raise the fresh tranche.
Founded in 2016 by Raghuraj Sunder Raju, Prasad Basavaraj, and Sandeep Gudibanda, HealthPlix Technologies helps doctors in digitising clinical operations and clinical treatment methodologies. HealthPlix also has a consumer mobile app which enables patients to avail video consultations with highly qualified specialist and super specialist doctors.
“We have been helping thousands of doctors in India to elevate their clinical practice to truly an evidence based treatment methodology using HealthPlix EMR and now we believe that we can use Real World Evidence (RWE) Platform to assess efficacy of various treatments being deployed and thus contribute our bit in the research of much needed COVID treatment,” said Sandeep Gudibanda, co-founder and CEO of HealthPlix Technologies.
The company currently claims to assist with more than 50,000 consultations on a daily basis across 12 medical specialties, in more than 180 cities across India.
“We believe that HealthPlix is uniquely positioned to take advantage of strong tailwinds that the Indian healthcare industry is experiencing in terms of increased medical information capture, interoperability, and automation,” said Gaurav Sachdeva, Managing Partner of JSW Ventures.
Healthplix has been valued around Rs 180 crore (post-money) in the Series B round. This is a 2.25X jump in the company’s valuation as compared to Rs 80 crore when it raised Series A round in April 2019.